Rare coexistence of dermatomyositis and smooth muscle antibodies, with abnormal liver function tests.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Works by Solanki, Kamal
Results: 15
1
2
Perspective of NO<sub>2</sub> Sensor Using Armchair-Graphene Nanoribbon via Dopant Engineering.
- Published in:
- Journal of Electronic Materials, 2025, v. 54, n. 8, p. 6204, doi. 10.1007/s11664-025-12026-y
- By:
- Publication type:
- Article
3
A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand.
- Published in:
- Clinical Rheumatology, 2015, v. 34, n. 11, p. 1921, doi. 10.1007/s10067-015-2981-3
- By:
- Publication type:
- Article
4
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study.
- Published in:
- Rheumatology, 2020, v. 59, n. 3, p. 580, doi. 10.1093/rheumatology/kez322
- By:
- Publication type:
- Article
5
Retention on anti-tumour necrosis factor therapy: the Waikato experience.
- Published in:
- New Zealand Medical Journal, 2015, v. 128, n. 1415, p. 34
- By:
- Publication type:
- Article
6
Insights into the Effects of Co-doping on the Electronic Properties of Armchair Graphene Nanoribbon-based NO<sub>2</sub> Gas Sensors.
- Published in:
- Journal of Electronic Materials, 2025, v. 54, n. 1, p. 300, doi. 10.1007/s11664-024-11539-2
- By:
- Publication type:
- Article
7
Adsorption Analysis at Critical Temperature of PM<sub>2.5</sub> Contaminants.
- Published in:
- IETE Journal of Research, 2024, v. 70, n. 5, p. 5139, doi. 10.1080/03772063.2023.2251445
- By:
- Publication type:
- Article
8
Direct and indirect health‐related costs of systemic sclerosis in New Zealand.
- Published in:
- International Journal of Rheumatic Diseases, 2022, v. 25, n. 12, p. 1386, doi. 10.1111/1756-185X.14433
- By:
- Publication type:
- Article
9
Correspondence reply to authors J A Vondenberg et: RE: Increased malignancies in systemic sclerosis (IJRD: IJRD‐2021‐0787).
- Published in:
- International Journal of Rheumatic Diseases, 2022, v. 25, n. 1, p. 93, doi. 10.1111/1756-185X.14271
- By:
- Publication type:
- Article
10
Increased malignancies in our Waikato cohort of patients with systemic sclerosis.
- Published in:
- International Journal of Rheumatic Diseases, 2021, v. 24, n. 4, p. 555, doi. 10.1111/1756-185X.14091
- By:
- Publication type:
- Article
11
Rituximab in diffuse cutaneous systemic sclerosis: should we be using it today?
- Published in:
- Rheumatology, 2015, v. 54, n. 5, p. 757, doi. 10.1093/rheumatology/keu463
- By:
- Publication type:
- Article
12
Significance of combined anti‐CCP antibodies and rheumatoid factor in a New Zealand cohort of patients with systemic sclerosis.
- Published in:
- International Journal of Rheumatic Diseases, 2018, v. 21, n. 7, p. 1430, doi. 10.1111/1756-185X.13330
- By:
- Publication type:
- Article
13
Mortality in the Waikato Hospital Systemic Sclerosis Cohort.
- Published in:
- International Journal of Rheumatic Diseases, 2018, v. 21, n. 1, p. 253, doi. 10.1111/1756-185X.13111
- By:
- Publication type:
- Article
14
Clinical utility of hypo- and hyperpigmentation of skin in diffuse cutaneous systemic sclerosis.
- Published in:
- International Journal of Rheumatic Diseases, 2017, v. 20, n. 6, p. 767, doi. 10.1111/1756-185X.13049
- By:
- Publication type:
- Article
15
A can of red herrings.
- Published in:
- International Journal of Rheumatic Diseases, 2010, v. 13, n. 3, p. e46, doi. 10.1111/j.1756-185X.2010.01535.x
- By:
- Publication type:
- Article